| P50 | author | William Couet | Q39755800 |
| | Nicolas Venisse | Q40834352 |
| P2093 | author name string | Emmanuel Garcion | |
| | Jean-Pierre Benoit | |
| | Jean-Christophe Olivier | |
| | Manuela Pereira de Oliveira | |
| P2860 | cites work | Latent reservoirs of HIV: obstacles to the eradication of virus | Q24615570 |
| | Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues | Q24633406 |
| | The influence of alkali fatty acids on the properties and the stability of parenteral O/W emulsions modified with solutol HS 15. | Q30844223 |
| | In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam | Q31035339 |
| | Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites | Q33832954 |
| | Potential role of ABC transporters as a detoxification system at the blood-CSF barrier. | Q33981559 |
| | The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors | Q34065800 |
| | Impact of drug transporter studies on drug discovery and development | Q34215229 |
| | Multidrug resistance genes and p-glycoprotein in the testis of the rat, mouse, Guinea pig, and human | Q34529233 |
| | How significant is the role of P-glycoprotein in drug absorption and brain uptake? | Q35677596 |
| | Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins | Q36108920 |
| | Drug concentration heterogeneity facilitates the evolution of drug resistance. | Q36312295 |
| | Increased accumulation of doxorubicin and doxorubicinol in cardiac tissue of mice lacking mdr1a P-glycoprotein | Q36617222 |
| | Barrier properties of testis microvessels | Q36688328 |
| | Interactions of Solutol HS 15 and Cremophor EL with plasma lipoproteins | Q36691154 |
| | The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues | Q36768537 |
| | Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy | Q39625779 |
| | Efficiency of nanoparticles as a carrier system for antiviral agents in human immunodeficiency virus-infected human monocytes/macrophages in vitro. | Q39782296 |
| | Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication | Q40673293 |
| | Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs | Q40688656 |
| | Targeted delivery of indinavir to HIV-1 primary reservoirs with immunoliposomes | Q40758597 |
| | Comparison of solutol HS 15, cremophor EL and novel ethoxylated fatty acid surfactants as multidrug resistance modification agents | Q41312990 |
| | Reversal of multidrug resistance phenotype by surfactants: relationship to membrane lipid fluidity | Q41346269 |
| | Protease inhibitors: a therapeutic breakthrough for the treatment of patients with human immunodeficiency virus | Q41471229 |
| | The effects of human immunodeficiency virus in the central nervous system | Q41729105 |
| | P-glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity | Q42549675 |
| | Intestinal metabolism promotes regional differences in apical uptake of indinavir: coupled effect of P-glycoprotein and cytochrome P450 3A on indinavir membrane permeability in rat. | Q43964615 |
| | Biodistribution of dual radiolabeled lipidic nanocapsules in the rat using scintigraphy and gamma counting | Q44101041 |
| | Simultaneous determination of five HIV protease inhibitors nelfinavir, indinavir, ritonavir, saquinavir and amprenavir in human plasma by LC/MS/MS. | Q44170173 |
| | Regulation of the Mdr1 isoforms in a p53-deficient mouse model | Q44177047 |
| | In vivo and in vitro assessment of baseline blood-brain barrier parameters in the presence of novel nanoparticles | Q44443873 |
| | Impact of Solutol HS 15 on the pharmacokinetic behavior of midazolam upon intravenous administration to male Wistar rats | Q44499171 |
| | P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins. | Q44658104 |
| | Physiological regulation of P-glycoprotein, MRP1, MRP2 and cytochrome P450 3A2 during rat ontogeny | Q48210892 |
| | The subpopulation of CF-1 mice deficient in P-glycoprotein contains a murine retroviral insertion in the mdr1a gene | Q48930048 |
| | Altered expression of hepatic cytochromes P-450 in mice deficient in one or more mdr1 genes. | Q54067076 |
| | Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance | Q68183435 |
| | Reversal of multi-drug resistance in vitro by fatty acid-PEG-fatty acid diesters | Q70842396 |
| | Inhibition of cytarabine-induced MDR1 (P-glycoprotein) gene activation in human tumor cells by fatty acid-polyethylene glycol-fatty acid diesters, novel inhibitors of P-glycoprotein function | Q71743175 |
| | Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells | Q72209104 |
| | Impact of Solutol HS 15 on the pharmacokinetic behaviour of colchicine upon intravenous administration to male Wistar rats | Q73277719 |
| | High-performance liquid chromatographic method for the determination of nelfinavir, a novel HIV-1 protease inhibitor, in human plasma | Q73706073 |
| | Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes | Q73811928 |
| | Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection | Q77737783 |
| | Electrokinetic properties of noncharged lipid nanocapsules: influence of the dipolar distribution at the interface | Q81686233 |
| P433 | issue | 11 | |
| P921 | main subject | indinavir | Q425490 |
| P304 | page(s) | 1898-1905 | |
| P577 | publication date | 2005-11-01 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Tissue distribution of indinavir administered as solid lipid nanocapsule formulation in mdr1a (+/+) and mdr1a (-/-) CF-1 mice | |
| P478 | volume | 22 | |